References
- Gudbrandsson T. Malignant hypertension: a clinical follow-up study with special reference to renal and cardiovascular function and immunogenetic factors. Acta Med Scand Suppl 1981; 650: 1–62
- Webster J, Petrie JC, Jeffers TA, et al. Accelerated hypertension: patterns of mortality and clinical factors affecting outcome in treated patients. Q J Med 1993; 86(8): 485–93
- Lip GY, Beevers M, Beevers G. The failure of malignant hypertension to decline: a survey of 24 years' experience in a multiracial population in England. J Hypertens 1994; 12(11): 1297–305
- Finnerty FA Jr. Hypertensive encephalopathy. AmJ Med 1972; 52(5): 672–8
- Beilin LJ, Goldby FS, Mohring J. High arterial pressure versus humoral factors in the pathogenesis of the vascular lesions of malignant hypertension. Clin Sei Mol Med 1977; 52(2): 111–7
- Kaplan NM. Hypertensive crises. In: Kaplan NM. Clinical hypertension. 6th ed. Baltimore: Williams & Wilkins, 1994: 281–97
- Calhoun DA, Oparil S. Treatment of hypertensive crisis. N Engl J Med 1990; 323(17): 1 177–83
- Kaplan NM. Primary hypertension: pathogenesis. In: Kaplan,” PP 47–108
- Muller FB, Sealey JE, Case DB, et al. The Captopril test for identifying renovascular disease in hypertensive patients. Am J Med 1986; 80(4): 633–44
- Kaplan NM. Pheochromocytoma. In: Kaplan,' pp 367–87
- Gifford RW Jr. Management of hypertensive crises. JAMA 1991; 266(6): 829–35
- Brogden RN, Markham A. Fenoldopam: a review of its pharmacodynamic and pharmacokinetic properties and intravenous clinical potential in the management of hypertensive urgencies and emergencies. Drugs 1997; 54(4): 634–50
- Shusterman NH, Elliott WJ, White WB. Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function. Am J Med 1993; 95(2): 161–8
- Fenoldopam (Corlopam) product information. Neurex Corporation, Menlo Park, Calif; Dec 1997
- Lavin P. Management of cerebral infarction or transient ischemic attacks. (Letter) Arch Intern Med 1990; 150(3): 692–4
- Houston MC, Hodge R. Beta-adrenergic blocker withdrawal syndromes in hypertension and other cardiovascular diseases. Am Heart J 1988; 116(2 Pt 1): 515–23
- Baer L, Parra-Carrilo JZ, Radichevich I, et al. Detection of renovascular hypertension with angiotensin II blockade. Ann Intern Med 1977; 86(3): 257–60